[Decision on therapeutic course and follow-up study of collagen diseases].
Kashiwagi
H
H
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001015:Aortic Arch Syndromes / Q000188:drug therapy / Q000601:surgery; D001528:Behcet Syndrome / Q000628:therapy; D003095:Collagen Diseases / Q000628:therapy*; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D008947:Mixed Connective Tissue Disease / Q000188:drug therapy; D012859:Sjogren's Syndrome / Q000628:therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008775:Methylprednisolone